Form 483

Pfizer Healthcare India Private Limited Form 483, 2018-09-21

FDA issued a Form 483 to Pfizer Healthcare India Private Limited on 2018-09-21 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Pfizer Healthcare India Private Limited · Visakhapatnam, India · Issued September 21, 2018

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Sep 2018
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Samina S Khan

21 Sep 2018
21 CFR 211.68(b)

Computer control of master formula records

Cited by Samina S Khan

21 Sep 2018
21 CFR 314.81(b)(1)(ii)

Failure to meet specifications

Cited by Samina S Khan

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x
21 CFR 314.81(b)(1)(ii)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere